See up to 3 months of MBX. The 7-day demo opens the 1M and 3M ranges and puts MBX on your watchlist.
Start 7-day demoLatest MBX insider trades
About MBX Biosciences, Inc. (MBX)
The SEC lists MBX Biosciences, Inc. under CIK 0001776111, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
MBX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 370 | $24K |
| Grant or award | 4 | 560,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
MBX insider transactions (Form 4)
4128 Form 4 filings on record, the earliest from Jun 5, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Salomon Azoulay - Officer | Open-market sale | Common Stock | 370 footnote F1 | $65.77 footnote F2 | $24K | |
| ||||||
 John W. Smither - Officer | Grant or award | Common Stock | 28,000 footnote F1 | $0.00 | - | |
| John W. Smither - Officer | Grant or award | Stock option (right to buy) | 130,000 | $0.00 | - | |
| ||||||
| Steven L. Hoerter - Officer | Grant or award | Common Stock | 71,000 footnote F1 | $0.00 | - | |
| Steven L. Hoerter - Officer | Grant or award | Stock option (right to buy) | 331,000 | $0.00 | - | |
| ||||||
| Edward T. Mathers | Grant or award | Stock option (right to buy) | 12,500 | $0.00 | - | |
| Ora H. Pescovitz | Grant or award | Stock option (right to buy) | 12,500 | $0.00 | - | |
| Patrick J. Heron | Grant or award | Stock option (right to buy) | 12,500 | $0.00 | - | |
| Laurie Stelzer | Grant or award | Stock option (right to buy) | 12,500 | $0.00 | - | |
| Steven L. Hoerter | Grant or award | Stock option (right to buy) | 12,500 | $0.00 | - | |
| Steven Ryder | Grant or award | Stock option (right to buy) | 12,500 | $0.00 | - | |
| Tiba Aynechi | Grant or award | Stock option (right to buy) | 12,500 | $0.00 | - | |
| Salomon Azoulay - Officer | Option exercise | Common Stock | 55,000 | $10.46 | $575K | |
| Salomon Azoulay - Officer | Open-market sale | Common Stock | 55,000 | $38.38 footnote F2 | $2.11M | |
| Salomon Azoulay - Officer | Option exercise | Common Stock | 15,003 | $16.00 | $240K | |
| Salomon Azoulay - Officer | Open-market sale | Common Stock | 15,003 | $38.30 footnote F3 | $575K | |
| Salomon Azoulay - Officer | Option exercise | Stock option (right to buy) | 55,000 | $0.00 | - | |
| Salomon Azoulay - Officer | Option exercise | Stock option (right to buy) | 15,003 | $0.00 | - | |
| ||||||
| Salomon Azoulay - Officer | Open-market sale | Common Stock | 231 footnote F1 | $29.54 footnote F2 | $7K | |
| ||||||
| P. Kent Hawryluk - Officer | Open-market sale | Common Stock | 607 | $29.54 footnote F2 | $18K | |
| ||||||
| Steven L. Hoerter | Grant or award | Common Stock | 11,938 footnote F1 | $0.00 | - | |
| Steven L. Hoerter | Grant or award | Stock option (right to buy) | 74,249 | $0.00 | - | |
| ||||||
| Steven L. Hoerter | Grant or award | Stock option (right to buy) | 0 | $0.00 | - | |
| P. Kent Hawryluk - Officer | Open-market purchase | Common Stock | 18,500 | $28.41 footnote F1 | $526K | |
| ||||||
| P. Kent Hawryluk - Officer | Option exercise | Common Stock | 28,768 | $16.00 | $460K | |
| P. Kent Hawryluk - Officer | Option exercise | Stock option (right to buy) | 28,768 | $0.00 | - | |
| Salomon Azoulay - Officer | Grant or award | Common Stock | 15,000 footnote F1 | $0.00 | - | |
| Salomon Azoulay - Officer | Grant or award | Stock option (right to buy) | 70,000 | $0.00 | - | |
| ||||||
| Richard Bartram - Officer | Grant or award | Common Stock | 15,000 footnote F1 | $0.00 | - | |
| Richard Bartram - Officer | Grant or award | Stock option (right to buy) | 70,000 | $0.00 | - | |
| ||||||
| P. Kent Hawryluk - Officer | Grant or award | Common Stock | 35,250 footnote F1 | $0.00 | - | |
| P. Kent Hawryluk - Officer | Grant or award | Stock option (right to buy) | 164,500 | $0.00 | - | |
| ||||||
| Laurie Stelzer | Grant or award | Stock option (right to buy) | 32,000 | $0.00 | - | |
| Steven L. Hoerter | Grant or award | Stock option (right to buy) | 8,000 | $0.00 | - | |
| Steven L. Hoerter | Grant or award | Stock option (right to buy) | 100,000 | $0.00 | - | |
| P. Kent Hawryluk - Officer | Option exercise | Common Stock | 182,859 | $3.25 | $594K | |
| P. Kent Hawryluk - Officer | Option exercise | Stock option (right to buy) | 182,859 | $0.00 | - | |
| P. Kent Hawryluk - Officer | Open-market purchase | Common Stock | 20,000 | $13.64 footnote F1 | $273K | |
| ||||||
| Steven L. Hoerter | Open-market purchase | Common Stock | 20,000 | $13.25 | $265K | |
| Patrick J. Heron | Open-market purchase | Common Stock | 666,666 | $18.00 | $12.00M | |
| James M. Cornelius | Grant or award | Stock option (right to buy) | 16,000 | $0.00 | - | |
Item 7.01, 8.01, 9.01
Item 2.02, 7.01, 8.01, 9.01
Item 5.02
Item 7.01, 8.01, 9.01
Recent MBX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Hawryluk P. Kent | Former Officer | 3,745 | $256K | View on EDGAR | |
| Hawryluk P. Kent | Officer | 936 | $62K |
MBX insider trading FAQ
What is the latest insider trade for MBX?
MBX Biosciences, Inc. (MBX) had 3 insider filings in the last 90 days, with the most recent on 2026-08-05. The full record for MBX runs to 28 Form 4 filings, the earliest from 2025-06-05. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MBX stock?
No insider purchases of MBX were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling MBX stock?
1 insider sale of MBX was filed in the last 90 days, totaling $24K.
Where can I see MBX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MBX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Salomon Azoulay view on EDGAR
- - John W. Smither view on EDGAR
- - Steven L. Hoerter view on EDGAR
- - Edward T. Mathers view on EDGAR
- - Ora H. Pescovitz view on EDGAR
- - Patrick J. Heron view on EDGAR
- - Laurie Stelzer view on EDGAR
- - Steven L. Hoerter view on EDGAR
- - Steven Ryder view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where MBX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MBX with a 7-day demo
- MBX on your watchlist
- Every MBX Form 4 filing on record
- Up to 3 months of MBX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
